论文部分内容阅读
最近DuBeshter等发现WHO预后评分系统较传统标准能更有效地预示高危的转移的滋养叶疾病患者结局。为此,作者进行了回顾性分析。作者对得克萨斯Anderson大学医院诊断为水泡状胎块、恶性葡萄胎、绒癌和妊娠滋养叶疾病的病人进行了医学记录研究,同时复习核对了测定hCG病人的化验室记录。根据传统标准将这些病人分为低危或高危组,病人如有一条符合传统高危标准即定为高危。为了按WHO标准评分,复习了病人的年龄、前次妊娠至治疗开始的间隔、hCG水
Recently, DuBeshter et al. Found that the WHO prognostic scoring system can more effectively predict the outcomes of high-risk metastatic trophoblastic diseases than the traditional criteria. To this end, the author conducted a retrospective analysis. The authors performed medical records of patients diagnosed with blisters, malignant mole, choriocarcinoma and gestational trophoblastic disease at Anderson University Hospital in Texas, and reviewed and verified laboratory records of hCG patients. These patients were classified into low-risk or high-risk groups according to the traditional criteria, and the patient was classified as at-risk if one met the traditional high-risk criteria. In order to score according to the WHO standard, reviewed the patient’s age, the last pregnancy to treatment interval, hCG water